Navigation Links
caprotec bioanalytics Announces Commercial Launch of Three New caproKits™ for Applications in Functional Proteomics and Drug Development
Date:9/30/2010

BERLIN and BURLINGTON, Mass., Sept. 30 /PRNewswire/ -- caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits™, enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development.

The three new kits are the Dasatinib caproKit, the C2 CAMP caproKit and the Biotin Capping Kit. Together, these new kits increase the number of commercially available caproKits to a total of 10.

The company's caproKits are based on the proprietary Capture Compound Mass Spectrometry (CCMS) technology, a novel and direct way to investigate small molecule–protein interactions resulting in a significant functional reduction of proteome complexity. Capture Compounds™ enable the direct isolation and identification of defined protein classes, including membrane proteins, out of complex biological samples.  

The new and existing caproKits target different areas of research ranging from signal transduction to epigenetics and proteases. The Dasatinib and C2 cAMP caproKits are the newest additions to the company's signal transduction product line. The Biotin Capping Kit is used to improve analytical performance by decreasing background noise when study samples contain a high amount of naturally biotin-modified proteins.  caproKits are versatile reagents and can be broadly used across different species and sources of sample material. Additional caproKits for applications in other research areas are under development and will be released in the coming months.

"We are pleased to now offer a broad suite of products specifically for kinases and nucleotide binding proteins, both being of paramount importance in signal transduction and drug discovery research," stated Dr. Hubert Koster, CEO of caprotec bioanalytics.  "Our new caproKits are innovative and effective chemical proteomics tools for researchers in need of a solution for targeted reduction of sample complexity."

About caprotec bioanalytics GmbH

caprotec bioanalytics is headquartered in Berlin, Germany with a US subsidiary in Burlington, MA. The company focuses on the commercialization of its proprietary Capture Compound Mass Spectrometry (CCMS) technology. The core of the CCMS technology consists of small, tri-functional molecules called Capture Compounds™. They enable a targeted isolation of proteins directly from complex biological samples. After isolation the captured proteins are identified and characterized by mass spectrometry or gel electrophoresis and Western blotting. Providing a state-of-the-art platform for the isolation and analysis of proteins from complex mixtures, the CCMS technology has enormous potential in proteomics, drug development and the development of biomarkers. The technology is protected by a broad patent portfolio.


'/>"/>
SOURCE caprotec bioanalytics GmbH
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche
2. Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
3. Repligen Announces Completion of Patient Enrollment in Phase 2b Clinical Trial of RG2417 for Bipolar Depression
4. Warner Chilcott Announces the Closing of its $500 Million Senior Notes Offering
5. BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock
6. UPDATE - ProUroCare Announces $3 Million Financing Agreement
7. Ascension Orthopedics Announces First Implantations of TITAN™ Modular Shoulder
8. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
9. CVS Caremark Announces 2010 Analyst Day
10. MAP Pharmaceuticals, Inc. Announces Pricing of Underwritten Registered Offering of Common Stock
11. Sun Pharma Announces Expiration of Subsequent Offering Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
Breaking Medicine News(10 mins):